Tema ETFs’s Edwards Lifesciences EW Stock Holding History

Tema ETFs’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$1.68M	Buy	19,499 +146	+0.8%	+$13K	0.06%	209
2026 Q2	$1.75M	Sell	19,353 -2,300	-11%	-$193K	0.06%	200
2026 Q1	$1.73M	Buy	21,653 +1,706	+9%	+$141K	0.12%	161
2025 Q4	$1.7M	Sell	19,947 -2,401	-11%	-$197K	0.13%	168
2025 Q3	$1.74M	Buy	22,348 +7,927	+55%	+$619K	0.14%	179
2025 Q2	$1.13M	Sell	14,421 -2,122	-13%	-$158K	0.3%	101
2025 Q1	$1.2M	Sell	16,543 -5,092	-24%	-$364K	0.36%	83
2024 Q4	$1.6M	Buy	+21,635	New	+$1.51M	0.67%	45

Other funds holding EW

Ninety One (UK) London, United Kingdom $45.5B AUM 15.2% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Birch Hill Investment Advisors Boston, Massachusetts $2.43B AUM 15.45% 1-Year Est. Return

Seilern Investment Management London, United Kingdom $771M AUM 2.59% 1-Year Est. Return

Ninety One North America New York $2.13B AUM 8.8% 1-Year Est. Return

Ninety One Cape Town, South Africa $2B AUM 34.6% 1-Year Est. Return

Vontobel Holding Zurich, Switzerland $27.7B AUM 21.75% 1-Year Est. Return

Fjarde Ap-fonden Stockholm, Sweden $19.4B AUM 31.69% 1-Year Est. Return

Fisher Funds Management Auckland, New Zealand $3.44B AUM 17.27% 1-Year Est. Return

Boston Common Asset Management Boston, Massachusetts $1.72B AUM 26.04% 1-Year Est. Return

Tema ETFs's EW Position: Q3 2026 in Review

Tema ETFs increased its Edwards Lifesciences (EW) stake by 0.75% in Q3 2026, buying an estimated $13K and bringing the position to 19,499 shares worth $1.68M. The position accounts for 0.06% of the portfolio, ranked #209.

Tema ETFs first reported a position in EW in Q4 2024 and has held it in 8 quarters since. The position peaked at $1.75M in Q2 2026. 212 funds tracked by Wall St. Rank hold EW as of Q3 2026.

Tema ETFs held 19,499 shares of Edwards Lifesciences worth $1.68M as of Q3 2026.
Tema ETFs bought 146 Edwards Lifesciences shares in Q3 2026, an estimated $13K.
Edwards Lifesciences made up 0.06% of Tema ETFs's portfolio in Q3 2026, its #209 holding.
Tema ETFs first reported a position in Edwards Lifesciences in Q4 2024 and has held it in 8 quarters since.
Tema ETFs's Edwards Lifesciences position peaked at $1.75M in Q2 2026.
212 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2026.

Based on Tema ETFs's 13F filing for Q3 2026, filed 16 Oct 2026.